Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
You do not have to manage this on your own
Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including statements about the supply treatment presentation, and access of Zepbound (tirzepatide) as a treatment for adults with obesity or overweight and reflects Lillys current belief and expectations
Yale JF, Bodholdt U, Catarig AM, et al
2 Although it can develop in anyone, OSA is more common among people with overweight or obesity and tends to worsen with age
US$ 29.11
US$ 26.07
US$ 23.78
US$ 26.40
US$ 22.50
